Big pharma executives and shareholders saw their wealth skyrocket in the week after the Omicron variant was discovered, with just eight top Pfizer and Moderna shareholders adding a combined $10.31 billion to their fortunes. Campaigners have accused pharma executives of “making a killing from a crisis they helped to create”, blaming “grotesque” levels of vaccine inequality for creating the conditions for the Omicron variant to emerge.
They are calling on governments to support a waiver of intellectual property rules on Covid-19 vaccines and treatments to allow low and middle-income countries to manufacture jabs for themselves, breaking big pharma monopolies and increasing overall supplies.
Moderna’s shares skyrocketed after the announcement and settled at $310.61/share on Wednesday 1 December, up 13.61% from $273.39/share since Wednesday 24 November, the day before
— source globaljustice.org.uk | 7 Dec 2021